News Releases

A $25 million gift from an anonymous donor to Penn Medicine and Children’s Hospital of Philadelphia (CHOP) created a center to study epilepsy and neurodevelopmental disorders.

A grant from the Warren Alpert Foundation will allow Penn Medicine to create state-of-the-art online courses for genetic counselors to continue their education. Penn will work with four other institutions around the nation to create the new program.

Making it possible to directly order and work with the results of genetic testing through patients’ electronic health records – instead of through third-party portals – resulted in significant time savings for clinicians, according to a new study.

After mapping the genetic underpinning of kidney function in 1.5 million people and about 60,000 kidney cells that are the microscopic mechanisms of gene regulation, over 500 genes likely contribute to kidney disease development, according to researchers at the Perelman School of Medicine at the University of Pennsylvania.

The protein TCF-1 enables various parts of otherwise insulated DNA segments to intermingle in a way that is required for the development of T cells—a key element of the body’s immune system—and the role this protein plays in T cell creation could shed new light on immunotherapy approaches, according to a new study by researchers at the Perelman School of Medicine at the University of Pennsylvania.

Generosity of Penn alumnus Michael Armellino creates center for care of patients with the rare genetic condition across all stages of life and propels scientific discovery

For the first time, researchers have revealed that during the development of Type 1 Diabetes (T1D), when insulin-producing cells in the pancreas are under attack from T lymphocytes, the cells lining the pancreatic duct reprogram themselves in an attempt to suppress autoimmune T cell responses.

Penn Medicine has been awarded a $9.5 million grant from The Warren Alpert Foundation (WAF) to continue its efforts to increase diversity in genetic counseling, a field that, despite impressive leaps forward in genetic knowledge, lacks a diverse workforce.

The Discovery Labs has signed a foundational lease with the University of Pennsylvania Gene Therapy Program (GTP), which will use Discovery Labs’ suburban campus for a portion of its expanding research operations focused on the development of genetic medicines for rare and orphan diseases, as well as acquired and pandemic infectious diseases, such as COVID-19.